Akademik Yayınlar

Ercelep O, Isık S, Ercan E, Kostek O, Bayoglu V at al. The Effect of PET/CT SUV max Value on Anti-EGFR Treatment Response in Lung Adenocarcinoma International Journal of Hematology and Oncology doi: 10.4999/uhod.257838 Number: 3 Volume: 35 Year: 2025

Ercelep O, Alan O, Sahin D, Telli TA, Salva H, Tuylu TB, Babacan NA, Kaya S, Dane F, Ones T, Alkis H, Adli M, Yumuk F. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer. Clin Transl Oncol. 2019 Apr;21(4):499-504. doi: 10.1007/s12094-018-1949-6. Epub 2018 Sep 18. PMID: 30229391.

Ercelep O, Alan O, Telli TA, Tuylu TB, Arıkan R, Demircan NC, Simsek ET, Babacan NA, Kaya S, Dane F, Bozkurtlar E, Ones T, Lacin T, Yumuk PF. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori. 2021 Jun;107(3):231-237. doi: 10.1177/0300891620950475. Epub 2020 Sep 2. PMID: 32878562.

Ercelep O, Gumus M. Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience. Curr Probl Cancer. 2019 Apr;43(2):160-166. doi: 10.1016/j.currproblcancer.2018.07.004. Epub 2018 Jul 21. PMID: 30122267.

Ercelep O, KESER S, Ozcelik M, Basar M. ACK1/TNK2 Tyrosine Kinase Overexpression Role in Gastric Cancer ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI ARTICLE International Journal of Hematology and Oncology UHOD Number: 2 Volume: 29 Year: 2019 doi: 10.4999/uhod.192412

Ercelep O, Ozcelik M, Gumus M. Association of lymphadenectomy and survival in epithelial ovarian cancer. Curr Probl Cancer. 2019 Apr;43(2):151-159. doi: 10.1016/j.currproblcancer.2018.08.002. Epub 2018 Aug 17. PMID: 30149960.

Ercelep O, Ozdemir N, Turan N, Topcu TO, Uysal M, Tanriverdi O, Demirci U, Taskoylu BY, Urakcı Z, Duran AO, Aksoy A, Menekse S, Ozcelik M, Gumus M. Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas. Curr Probl Cancer. 2019 Feb;43(1):27-32. doi: 10.1016/j.currproblcancer.2018.06.014. Epub 2018 Jul 19. PMID: 30104029.

Ercelep O, Topcu TO, Bayoglu IV, Ekinci AS, Koca S, Kavgaci H, Ozcelik M, Alacacioglu A, Uzunoglu S, Bozkurt O, Ulas A, Aksoy A, Taskoylu BY, Gumussay O, Yaman S, Uysal M, Aydin D, Gumus M. Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology. Tumour Biol. 2016 Sep;37(9):12033-12038. doi: 10.1007/s13277-016-5076-0. Epub 2016 May 12. PMID: 27173124.

Ercelep OB, Caglar E, Dobrucali A. The prevalence of gastroesophageal reflux disease among hospital employees. Dis Esophagus. 2014 Jul;27(5):403-8. doi: 10.1111/j.1442-2050.2012.01402.x. Epub 2012 Sep 28. PMID: 23020266.

Ercelep Ö, 1 Telli TA, Alan Ö, Hasanov R, Şimşek ET, Babacan NA, Kaya S, Kaya H, Dane F, Yumuk F Smokers having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience Turk J Oncol 2020;35(3):334–9 doi: 10.5505/tjo.2020.2207

Akdeniz N, Küçüköner M, Kaplan MA, Urakçı Z, Karhan O, Sezgin Y, Bilen E, Ebinç S, Teke F, Laçin Ş, Alan Ö, Ercelep Ö, Işıkdoğan A, Yumuk PF. Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer. Int J Clin Oncol. 2020 Dec;25(12):2015-2024. doi: 10.1007/s10147-020-01767-x. Epub 2020 Aug 14. PMID: 32797321.

Alan O, Akin Telli T, Aktas B, Koca S, Ökten IN, Hasanov R, Basoglu T, Arikan R, Demircan NC, Ercelep O, Kaya S, Ugurlu MU, Kaya H, Akgul Babacan N, Dane F, Yumuk PF. Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment? World J Surg Oncol. 2020 Sep 9;18(1):242. doi: 10.1186/s12957-020-02019-y. PMID: 32907593; PMCID: PMC7488234.

Alan O, Akin Telli T, Ercelep O, Tanrikulu Simsek E, Basoglu Tuylu T, Mutis A, Hasanov R, Kaya S, Akgül Babacan N, Dane F, Yumuk PF. Chordoma: a case series and review of the literature. J Med Case Rep. 2018 Aug 27;12(1):239. doi: 10.1186/s13256-018-1784-y. PMID: 30145982; PMCID: PMC6109974.

Alan O, Telli TA, Basoğlu T, Arikan R, Demircan NC, Ercelep O, Bozkurt S, Atasoy BM, Dane F, Yumuk PF. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment. Clin Neurol Neurosurg. 2020 Sep;196:105976. doi: 10.1016/j.clineuro.2020.105976. Epub 2020 May 30. PMID: 32531614.

Alan O, Telli TA, Basoğlu T, Arikan R, Demircan NC, Ercelep O, Sakar M, Bozkurt S, Atasoy BM, Dane F, Ziyal Mİ, Yumuk PF. Impact of prognostic nutritional index on survival in recurrent glioblastoma. Neurocirugia (Astur : Engl Ed). 2021 Jan 13:S1130-1473(20)30136-6. English, Spanish. doi: 10.1016/j.neucir.2020.11.005. Epub ahead of print. PMID: 33454185.

Alan O, Telli TA, Ercelep O, Hasanov R, Simsek ET, Mutis A, Ones T, Kaya H, Yumuk PF. A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy. Curr Probl Cancer. 2019 Aug;43(4):308-311. doi: 10.1016/j.currproblcancer.2018.04.003. Epub 2018 May 9. PMID: 29880396.

Arıkan R, Telli TA, Demircan NC, Başoğlu T, Ercelep Ö, Atasoy BM, Özgüven S, Dane F, Yumuk PF. Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature. Curr Probl Cancer. 2021 Apr;45(2):100668. doi: 10.1016/j.currproblcancer.2020.100668. Epub 2020 Oct 22. PMID: 33127167.

Aydin D, Bilici A, Yavuzer D, Kefeli U, Tan A, Ercelep O, Mert A, Yuksel S, Ozcelik M, Isik D, Surmeli H, Odabasi H, Aliustaoglu M. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy. Clin Transl Oncol. 2015 Aug;17(8):604-11. doi: 10.1007/s12094-015-1283-1. Epub 2015 Mar 19. PMID: 25786367.

Aydin D, Sendur MA, Kefeli U, Ustaalioglu BB, Aydin O, Yildirim E, Işık D, Ozcelik M, Surmeli H, Oyman A, Işık S, Sener N, Ercelep Ö, Odabas H, Aliustaoglu M, Gumus M (2017). Evaluation Of Bevacizumab in Advanced Small Bowel Adenocarcinoma. Clin Colorectal Cancer, Doi: 10.1016/J.Clcc.2016.04.013.

Basoglu T, Telli TA, Demircan NC, Arikan R, Ercelep O, Ozguven S, Soysal S, Memisoglu A, Dane F, Yumuk PF. A rare case of gastric cancer with bilateral breast metastasis during pregnancy. J Oncol Pharm Pract. 2021 Jan;27(1):220-226. doi: 10.1177/1078155220925156. Epub 2020 May 23. PMID: 32448025.

Başoğlu T, Akar KE, Bağcı P, Akgül Babacan N, Öztürk MA, Öztürk FE, Demircan NC, Arikan R, Akın Telli T, Ercelep Ö, Dane F, Yumuk PF. Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma. Balkan Med J. 2021 Dec 20. doi: 10.5152/balkanmedj.2021.21122. Epub ahead of print. PMID: 34928235.

Cicin İ, Özatlı T, Türkmen E, Özturk T, Özçelik M, Çabuk D, Gökdurnalı A, Balvan Ö, Yıldız Y, Şeker M, Özdemir N, Yapar B, Tanrıverdi Ö, Günaydin Y, Menekşe S, Öksüzoğlu B, Aksoy A, Erdogan B, Bekir Hacıoglu M, Arpaci E, Sevinç A. Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas. Balkan Med J. 2016 Sep;33(5):517-524. doi: 10.5152/balkanmedj.2016.151268. Epub 2016 Sep 1. PMID: 27761279; PMCID: PMC5056654.

Demircan NC, Akın Telli T, Başoğlu Tüylü T, Arıkan R, Kocakaya D, Şahin AA, Ercelep Ö, Dane F, Yumuk PF. QT interval prolongation related to afatinib treatment in a patient with metastatic non-small-cell lung cancer. Curr Probl Cancer. 2020 Dec;44(6):100594. doi: 10.1016/j.currproblcancer.2020.100594. Epub 2020 May 27. PMID: 32505368.

Demircan NC, Alan Ö, Başoğlu Tüylü T, Akın Telli T, Arıkan R, Çiçek FC, Ercelep Ö, Öztürk MA, Alsan Çetin İ, Ergelen R, Tinay İ, Akgül Babacan N, Kaya S, Dane F, Yumuk PF. Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib. J Oncol Pharm Pract. 2020 Jul;26(5):1147-1155. doi: 10.1177/1078155219890032. Epub 2019 Dec 2. PMID: 31793376.

Demircan NC, Dane F, Ozturk MA, Babacan NA, Besiroglu M, Kaya S, Ercelep O, Tanrikulu E, Halil S, Koca S, Alan O, Hasanov R, Yumuk PF. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy. J BUON. 2019 Jul-Aug;24(4):1494-1500. PMID: 31646797.

Demirelli B, Babacan NA, Ercelep Ö, Öztürk MA, Kaya S, Tanrıkulu E, Khalil S, Hasanov R, Alan Ö, Telli TA, Koca S, Arıbal ME, Kuzan B, Dane F, Yumuk PF. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. Nutr Cancer. 2021;73(2):230-238. doi: 10.1080/01635581.2020.1749290. Epub 2020 Apr 9. PMID: 32270713.

Dinc NS, Aydın K, Odabas H, Ercelep O, Tufan G, Seker M, Yasar N, Aydin D, Yuksel S, Mert A, Ozcelik M, Korkmaz T, Yildiz R, Aliustaoglu M, Mayadagli A, Dane F, Gumus M. Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer. Oncol Res Treat. 2016;39(3):130-4. doi: 10.1159/000444272. Epub 2016 Feb 23. PMID: 27030981.

Gumusay O, Coskun U, Akman T, Ekinci AS, Kocar M, Erceleb OB, Yazıcı O, Kaplan MA, Berk V, Cetin B, Taskoylu BY, Yildiz A, Goksel G, Alacacioglu A, Demirci U, Algin E, Uysal M, Oztop I, Oksuzoglu B, Dane F, Gumus M, Buyukberber S. Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology. J Cancer Res Clin Oncol. 2014 Jan;140(1):151-7. doi: 10.1007/s00432-013-1553-7. Epub 2013 Nov 29. PMID: 24292400.

Kaya S, Aktas B, Tanrikulu Sismek E, Akif Ozturk M, Dede F, Kaya H, Ugurlu U, Ozgen Z, Koca S, Halil S, Hasanov R, Alan O, Akgul Babacan N, Ercelep O, Dane F, Gumus M, Yumuk F. Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer. J BUON. 2017 Sep-Oct;22(5):1191-1198. PMID: 29135102.

Kefeli U, Yildirim ME, Aydin D, Madenci OC, Yasar N, Sener N, Mert AG, Yuksel S, Ercelep OB, Korkmaz T, Yildiz R, Gumus M. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers. 2012 Nov;17(7):663-7. doi: 10.3109/1354750X.2012.709882. Epub 2012 Aug 13. PMID: 22889408.

Korkmaz T, Seber S, Kefeli U, Sari E, Canhoroz M, Oven B, Yildirim E, Yasar N, Aydin D, Balvan O, Sener N, Yuksel S, Mert A, Polat O, Yumuk F, Kanat O, Gumus M, Turhal NS. Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis. Clin Transl Oncol. 2013 Jul;15(7):535-40. doi: 10.1007/s12094-012-0960-6. Epub 2012 Nov 10. PMID: 23143955.

Oruc Z, Kaplan MA, Geredeli C, Yildirim Sari N, Ozaslan E, Aytekin A, Tamer Elkiran E, Koca S, Dogan M, Turan N, Yuce O, Sevinc A, Ercelep O, Isikdogan A. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study. J BUON. 2020 Mar-Apr;25(2):641-647. PMID: 32521847.

Oven Ustaalioglu BB, Balvan O, Bilici A, Develi A, Aliustaoglu M, Vardar FA, Erkol B. The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival. Clin Transl Oncol. 2015 Nov;17(11):895-902. doi: 10.1007/s12094-015-1323-x. Epub 2015 Jun 17. PMID: 26081286.

Ozcelik M, Korkmaz T, Odabas H, Gemici C, Ercelep O, Yuksel S, Mert AG, Surmeli H, Isik D, Aydin D, Seker M, Mayadagli A, Ozdemir P, Aliustaoglu M, Gumus M. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients. Tumour Biol. 2016 Jul;37(7):8901-7. doi: 10.1007/s13277-015-4776-1. Epub 2016 Jan 11. PMID: 26753955.

Ozcelik M, Odabas H, Ercelep O, Yuksel S, Mert AG, Aydin D, Surmeli H, Isik D, Isik S, Oyman A, Oven Ustaalioglu BB, Aliustaoglu M, Gumus M. The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients. Clin Transl Oncol. 2016 Jun;18(6):617-24. doi: 10.1007/s12094-015-1408-6. Epub 2015 Oct 12. PMID: 26459249.

Ozcelik M, Seker M, Eraslan E, Koca S, Yazilitas D, Ercelep O, Ozaslan E, Kaya S, Hacibekiroglu I, Menekse S, Aksoy A, Taskoylu BY, Varol U, Arpaci E, Ciltas A, Oksuzoglu B, Zengin N, Gumus M, Aliustaoglu M. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology. Tumour Biol. 2016 Apr;37(4):5231-7. doi: 10.1007/s13277-015-4359-1. Epub 2015 Nov 10. PMID: 26553363.

Özçelik M, Ercelep Ö, Keser S, Özdemir NB, Başar M, Odabaş H, Oyman A, Işık S, Özçelik S, Aliustaoğlu M (2020). PTK-7 Expression in Gastric Cancer: A Prognostic Determinant. Balkan Med J, Doi:10.4274/Balkanmedj.Galenos.2019.2019.8.12. Epub 2019 Dec 10.

Özçelik M, Odabaş H, Ercelep Ö, Yüksel S, Mert AG, Aydın D, Sürmeli H, Işık D, Işık S, Oyman A, Ustaalioğlu BBÖ, Aliustaoğlu M, Gümüş Mahmut (2015). The Efficacy and Safety of Capecitabine plus Bevacizumab Combination As First-Line Treatment In Elderly Metastatic Colorectal Cancer Patients. Clinical And Translational Oncology, Doi: 10.1007/S12094-015-1408-6.

Telli TA, Demircan NC, Alan O, Tuylu TB, Arikan R, Ercelep O, Atıcı AE, Ergelen R, Seven IE, Babacan NA, Kaya S, Dane F, Fulden Yumuk P. A rare case of primary rectal choriocarcinoma and review of the literature. J Oncol Pharm Pract. 2020 Jun;26(4):989-994. doi: 10.1177/1078155219875510. Epub 2019 Sep 23. PMID: 31547751.

Turan N, Benekli M, Dane F, Unal OU, Kara HV, Koca D, Balvan O, Eren T, Tastekin D, Helvaci K, Berk V, Demirci U, Ozturk SC, Dogan E, Cetin B, Kucukoner M, Tonyali O, Tufan G, Oztop I, Gumus M, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer. Thorac Cancer. 2014 Sep;5(5):398-404. doi: 10.1111/1759-7714.12107. Epub 2014 Aug 25. PMID: 26763794; PMCID: PMC4704370.

Turan N, Benekli M, Unal OU, Unek İT, Tastekin D, Dane F, Algın E, Ulger S, Eren T, Topcu TO, Turkmen E, Babacan NA, Tufan G, Urakci Z, Ustaalioglu BO, Uysal OS, Ercelep OB, Taskoylu BY, Aksoy A, Canhoroz M, Demirci U, Dogan E, Berk V, Balakan O, Ekinci AŞ, Uysal M, Petekkaya İ, Ozturk SC, Tonyalı Ö, Çetin B, Aldemir MN, Helvacı K, Ozdemir N, Oztop İ, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma. Chin J Cancer Res. 2015 Aug;27(4):408-16. doi: 10.3978/j.issn.1000-9604.2015.08.03. PMID: 26361410; PMCID: PMC4560744.

Dogan, I.; Aksoy, S.; Cakar, B.; Basaran, G.; Ercelep, O.; Molinas Mandel, N.; Korkmaz, T.; Gokmen, E.; Sener, C.; Aydiner, A.; et al. Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group. Cancers 2023, 15, 1667. https://doi.org/10.3390/cancers15061667

Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut, Didem Taştekin, Arif Akyıldız, Serkan Yaşar, Şuayib Yalçın, Eyüp Çoban, Türkkan Evrensel, Ziya Kalkan, Zeynep Oruç, Sümeyra Derin, Zeynep Hande Turna, Doğan Bayram, Fahriye Tuğba Köş, Mehmet Ali Nihat Şendur, Nadiye Sever, Özlem Ercelep, Mustafa Seyyar, Umut Kefeli, Kazım Uygun, Melike Özçelik, Sercan Ön, Ulus Ali Şanlı, Kübra Canaslan, İlkay Tuba Ünek, Kadriye Bir Yücel, Nuriye Özdemir, Ozan Yazıcı, Halil Göksel Güzel, Derya Kıvrak Salim, Sema Sezgin Göksu, Ali Murat Tatlı, Çetin Ordu, Oğuzhan Selvi, Abdullah Sakin, Mehmet Emin Büyükbayram, Bengü Dursun, Yüksel Ürün, Hacı Arak, Gözde Ağdaş, Muzaffer Uğraklı, Engin Hendem, Melek Karakurt Eryılmaz, Burak Bilgin, Atakan Topçu, Melih Şimşek, Mahmut Büyükşimşek, Büşra Akay, Gülçin Şahingöz Erdal, Fatih Karataş, Özkan Alan, Melek Çağlayan, Fatma Akdağ Kahvecioğlu, Ayşe Demirci, Nail Paksoy, Bülent Çetin, Mahmut Gümüş, Naziye Ak, Yasemin Aydınalp, Semra Paydaş, Deniz Can Güven, Saadettin Kılıçkap, Sezer Sağlam, Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group, The Oncologist, Volume 28, Issue 10, October 2023, Pages 875–884, https://doi.org/10.1093/oncolo/oyad257

Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, Didem Tastekin, Senem Karabulut, Abidin Gündogdu, Nadiye Sever, Murat Ayhan, Abdussamed Çelebi, Nargiz Majidova, Alper Yaşar, Yeşim Ağyol, Pınar Erel, Erkam Kocaaslan, Ali Kaan Güren, Rukiye Arıkan, Selver Isık, Ozlem Ercelep, Sema Sezgin Goksu, Celal Alandag, İrem Bilgetekin, Burcu Caner, Ahmet Bilge Sahin, Ahmet Gulmez, Baran Akagunduz, Fatih Kose, Muhammet Ali Kaplan, Ender Dogan, Teoman Sakalar, Deniz Can Guven, Mustafa Gurbuz, Yakup Ergun, Mustafa Karaagac, Sema Turker, Ozlem Ozkul, Birol Yıldız, Süleyman Sahin, Atike Gokcen Demiray, Murat Sari, Bülent Erdogan, İlhan Hacıbekiroglu, Ömür Berna Çakmak Öksüzoğlu, Saadettin Kilickap, Ahmet Bilici, İbrahim Vedat Bayoglu, Sernaz Topaloglu & İrfan Cicin (2024) The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing, Journal of Chemotherapy, DOI: 10.1080/1120009X.2024.2305066

Arikan R, Ozguven S, Telli TA, et al. Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters. Acta Radiologica. 2023;64(5):2040-2049. doi:10.1177/02841851221140504

Ahmet Ozveren, Derya Hopanci Bicakli, Gamze Gultekin, Timucin Cil, Dilek Dogan, Canan Zengin, Ahmet Bilici, Songül Sabir, Ozlem Ercelep, Feyzanur Eksi, Fatih Selcukbiricik, Meltem Yilmaz, Gozde Ergene, Ali Murat Tatli, Feray Karsli Aksoy, Omer Dizdar, Hasan Çağrı Yıldırım, Nesrin Ozmen, Ulus Ali Sanli, and Bulent Karabulut Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study.. JCO 42, 741-741(2024).DOI:10.1200/JCO.2024.42.3_suppl.741

Bayoğlu, İbrahim Vedat, Javid Hüseynov, Alper Topal, Nadiye Sever, Nargiz Majidova, Abdussamet Çelebi, Alper Yaşar, Rukiye Arıkan, Selver Işık, Muhammet Bekir Hacıoğlu, , Özlem Ercelep et al. 2023. "PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score" Journal of Clinical Medicine 12, no. 19: 6420. doi.org/10.3390/jcm12196420

Tugba Akin Telli a, Ozkan Alan a f, Nazim Can Demircan a, Nisanur Sariyar b, Rukiye Arikan a, Tugba Basoglu a, Alper Yasar a, Abdussamet Celebi a, Selver Isik a, Omer Sofulu c, Bulent Erol c, Huseyin Kemal Turkoz d, Zerrin Ozgen e, Ozlem Ercelep a, Faysal Dane a, Perran Fulden Yumuk a f Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities Orthopaedics & Traumatology: Surgery & Research Volume 109, Issue 3, May 2023, 103491

Basoglu, Tugba; Babacan, Nalan A.1; Ozturk, Fatih E.2; Arikan, Rukiye; Demircan, Nazim C.; Telli, Tugba Akin; Ercelep, Ozlem; Dane, Faysal; Yumuk, Perran F.. Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma. Indian Journal of Cancer 60(2):p 179-184, Apr–Jun 2023. | DOI: 10.4103/ijc.IJC_1049_20

Arikan, R., Atci, M. M., Ay, S., Ayhan, M., Demircan, N. C., Telli, T. A., Çelebi, A., Yaşar, A., Işik, S., Celikel, C., Balvan, O., Bayoglu, I. V., Kostek, O., Dane, F., Yumuk, P. F."Prognostic significance of mucinous histology in left-sided metastatic colorectal cancers with wild-type RAS and evaluation of backbone chemotherapy regimens". Oncology Letters 25.5 (2023): 208.

Cihan Erol; Emre Yekedüz; Deniz Tural; Serdar Karakaya; Nihan Şentürk Öztaş; Gökhan Uçar Saadettin Kılıçkap; İsmail Ertürk; Özlem Nuray Sever; Çağatay Arslan; Ahmet Küçükarda; Orçun Can; Özlem Balvan; Satı Coşkun Yazgan; Mustafa Özgüroğlu; Berna Öksüzoğlu; Mehmet Ali Nahit Şendur; Yüksel Ürün Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium Urol Int (2023) 107 (6): 595–601.https://doi.org/10.1159/000528994

Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur & Yüksel Ürün The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors Nature 2045-2322/doi.org/10.1038/s41598-022-20056-3

Emre Yekedüz, Deniz Tural, İsmail Ertürk, Serdar Karakaya, Cihan Erol, Özlem Ercelep, Çağatay Arslan, Özlem Nuray Sever, Saadettin Kılıçkap, Nihan Şentürk Öztaş, Ahmet Küçükarda, Orçun Can, Berna Öksüzoğlu, Mehmet Ali Şendur, Nuri Karadurmuş & Yüksel Ürün The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study Journal of Cancer Research and Clinical Oncology Volume 148, pages 3537–3546, (2022) DOI: 10.1007/s00432-022-04055-5

Tugba Akin Telli Onur Bugdayci, Ozkan Alan, Nisanur Sariyar, Selver Isik, Rukiye Arikan Icon, Alper Yasar, Nargiz Majidova, Abdussamet Celebi, Bulent Erol, Zerrin Ozgen, Osman Kostek, Ibrahim Vedat Bayoglu, Ozlem Ercelep, Faysal Dane &Perran Fulden Yumuk Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma Nutrition and Cancer Volume 74, 2022 - Issue 7 https://doi.org/10.1080/01635581.2022.2063349

Nargiz MAJIDOVA1, Fatih SIMSEK2, Sedat BITER3, Sendag YASLIKAYA3, Mustafa SEYYAR4, Mustafa Emre DUYGULU5, Murat ARCAGOK6, Muhammed Fatih KIRCALI2, Nadiye SEVER1, Erkam KOCAASLAN1, Pinar EREL1, Yesim AGYOL1, Ali Kaan GUREN1, Abdussamet CELEBI1, Rukiye ARIKAN1, Selver ISIK1, Ozlem ERCELEP1, Murat SARI1, Ibrahim Vedat BAYOGLU1, Osman KOSTEK1Prognostic Factors Associated with Resected Osteosarcoma: Efficacy of Adjuvant Setting, Real-World ExperienceNumber: 1 Volume: 34 Year: 2024 1 ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI ARTICLE International Journal of Hematology and Oncology doi: 10.4999/uhod.

Nargiz Majidova; Murat Sari; Fatma Akdag Kahvecıglu; Erkan Ozcan; Mutıanur Ozkorkmaz Akdag; Akıf Dogan; Sedat Yıldırım; Sermın Dınc Sonusen; Emıl Yunusov; Alper Yasar; Abdussamet Celebi; Nadıye Sever; Erkam Kocaaslan; Pınar Erel; Yesım Agyol; Ali Kaan Guren; Rukiye Arikan; Selver Işık; Ozlem Balvan; Caglayan Geredeli; Kazım Uygun; Ilhan Hacıbekiroğlu; Osman Kostek; İbrahim Vedat Bayoğlu Clinicopathologic Features And Efficacy Of Induction Chemotherapy In Nasopharyngeal Carcinoma: Real-World Experience Oncol Res Treat 1.https://doi.org/10.1159/000537988

Sever, N., Yildirim, S., Yildiz, H. S., SONUSEN, S. D., CELEBI, A., Majidova, N.,... & Kostek, O. (2024). Long-Term Survival and Disease-Free Rates in Locoregional Anal Squamous Cell Carcinoma: An Institutional Experience. International Journal of Hematology and Oncology, 34(4), 213-219.

Sever, N., Şimşek, F., Onur, İ. D., Arvas, H., Guliyev, T., Şakalar, T.,... & Bayoğu, İ. V. (2025). Prognostic factors in high grade osteosarcoma patients who received neoadjuvant therapy and subsequently underwent surgery: data from the Turkish oncology group. Journal of Clinical Medicine, 14(6), 2024.

Sever, N., Yunusov, E., Çelebi, A., Yaşar, A., Majidova, N., Kocaaslan, E.,... & Sarıc, M. (2025). Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer. Annals of Saudi Medicine, 45(1), 18-24.

Majidova, N., Seyyar, M., Bayraktar, D. I., Dinç, G., Isgandarov, E., Huseynov, J.,... & Sarı, M. (2024). Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multicenter study. Biomolecules and Biomedicine, 24(6), 1785.

Arıkan, R., Demircioğlu, Ö., Özgüven, S., Demircan, N. C., Alan, Ö., Telli, T. A.,... & Yumuk, P. F. (2024). Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapy. Indian Journal of Cancer, 61(4), 789-796.

Güren, A. K., Majidova, N., Çakır, İ., Sever, N., Kocaaslan, E., Erel, P.,... & Köstek, O. (2025). Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients. Middle East Journal of Cancer, 16(2), 162-169.

Deliktaş Onur, İ., BAŞOĞLU TÜYLÜ, T. U. Ğ. B. A., Demircan, N. A. Z. I. M., Akin Telli, T., Arikan, R., Ercelep, Ö.,... & Dane, F. (2024). Evaluating the performance of the Mskcc gastric cancer survıval calculator in the Turkısh population. Turkish Journal of Medical Sciences, 54(6), 1205-1214.

Demircan NC, Tekin MF, Akın Telli T, Arıkan R, Başoğlu T, Çelebi A, Yaşar A, Işık S, Ercelep Ö, Dane F, Ataizi Çelikel Ç, Yumuk PF. Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups. Future Oncol. 2025 Nov;21(26):3425-3434. doi: 10.1080/14796694.2025.2567845. Epub 2025 Oct 5. PMID: 41047636; PMCID: PMC12582108.

Ercelep Ö, Tataroğlu D, Özçelik M, Sürmeli H, Değirmenci M, İnanç M, Aliustaoğlu M, Gümüş M. Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer. Turk J Obstet Gynecol. 2020 Jun;17(2):123-127. doi: 10.4274/tjod.galenos.2020.90699. Epub 2020 Jul 29. PMID: 32850187; PMCID: PMC7406906.

Ercelep O, Alan O, Telli TA, Tuylu T, Arikan R, Demircan N, Kocakaya D, Dane F, Lacin T, Bozkurtlar E, Yumuk PF Comparison of Seventh and Eighth Editions of TNM Staging Classification and Evaluation of Survivals in Operated Non-Small Cell Lung Carcinomas: Single Center Experience EJMI 2020;4(2):243–246 DOI: 10.14744/ejmi.2020.81008 EJMI 2020;4(2):243–246

Ercelep Ö, 1 Telli TA, Alan Ö, Hasanov R, Şimşek ET, Babacan NA, Kaya S, Kaya H, Dane F, Yumuk F Smokers having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment –Single-Center Experience Turk J Oncol 2020;35(3):334–9 doi: 10.5505/tjo.2020.2207

Veysel Başar, 1 N. Onur Ermerak, 2 Şehnaz Olgun Yıldızeli, 3 Emine Bozkurtlar, 4 Özlem Ercelep, 5 Bülent Mutlu, 6 Derya Kocakaya, 3 G. Nural Bekiroğlu, 7 Serpil Taş, 1 Mehmed Yanartaş, 1 Hasan Sunar, 1 Koray Ak, 8 Serdar Küçükoğlu, 9 and Bedrettin Yıldızeli Results of surgical treatment of pulmonary artery sarcomas: Does histology affect survival? Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Jul; 31(3): 388–397. Published online 2023 Jul 27. doi: 10.5606/tgkdc.dergisi.2023.23906

Ustaalioğlu BBÖ, Tilki M, Sürmelioğlu A, Bilici A, Gönen C, Ustaalioğlu R, Balvan Ö, Aliustaoğlu M. The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification. Turk J Surg. 2017 Mar 1;33(1):18-24. doi: 10.5152/UCD.2017.3379. PMID: 28589183; PMCID: PMC5448566.

Tugba Basoglu, 1 Salih Ozguven, 2 Ceren Ozge Engur, 2 Firat Akagunduz, 3 Nazim Can Demircan, 1 Rukiye Arikan, 1 Fatma Temiz, 3 Selma Sengun, 3 Selver Isik, 1 Tugba Akin Telli, 1 Abdussamed Celebi, Alper Yasar, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk, Prognostic Value Of PET/CT Determined Sarcopenia inPatients with Resected Ampullary Carcinoma DOI: 10.14744/ejmi.2023.28845 EJMI 2023;7(1):32–41

Tugba Akin Telli, 1 Nisanur Sariyar, 2 Ozkan Alan, 1 Nazim Can Demircan, 1 Selver Isik, 1 Rukiye Arikan, 1 Tugba Basoglu, 1 Alper Yasar, 1 Abdussamet Celebi, 1 Omer Sofulu, 3 Bulent Erol, 3 Huseyin Kemal Turkoz, 4 Zerrin Ozgen, 5 Ozlem Ercelep, 1 Faysal Dane, 1 Perran Fulden Yumuk1 Preoperative Prognostic Nutritional Index is a Strong Predictor of Survival in Patients with Localized Soft Tissue Sarcoma DOI: 10.14744/ejmo.2021.74738 EJMI 2021;5(2):256–262

Tugba Basoglu, 1 Nazim Can Demircan, 1 Tugce Kubra Gunes, 2 Mehmet Umut Capar, 2 Merve Cinar, 2 Rukiye Arikan, 1 Tugba Akin Telli, 1 Ozlem Ercelep, 1 Faysal Dane, 1 Perran Fulden Yumuk1 A Laboratory Prognostic Index Model for Predicting Survival in Patients with Malignant Pleural Mesothelioma DOI: 10.14744/ejmi.2022.38653 EJMI 2022;6(3):352–358

Tuğba Başoğlu, Nazım Can Demircan, Rukiye Arıkan, Tugba Akın Telli, Selver Işık, Alper Yasar, Abdussamet Çelebi, Özlem Ercelep, Faysal Dane, Perran Fulden Yumuk Comparison of Resected Ampullary and Pancreatic Head Carcinomas: A Single-Center Experience DOI: 10.14744/scie.2022.95815 South. Clin. Ist. Euras. 2022;33(3):326-330

Rukiye Arikan, 1 Tugba Akin Telli, 1 Ozkan Alan, 1 Nazim Can Demircan, 1 Tugba Basoglu, 1 Ozlem Ercelep, 1 Handan Kaya, 2 Onur Bugdayci, 3 Umit Ugurlu, 4 Zerrin Ozgen, 5 Faysal Dane, 1 Perran Fulden Yumuk1 1 Department of Internal Medicine, Division of MediClinicopathologic and Radiologic Characteristics of Pleomorphic Lobular Breast Cancer DOI: 10.14744/ejmi.2021.76855 EJMI 2021;5(1):148–152

Rukiye Arikan, Tugba Akin Telli, Selver Isik, Murat Sari, Osman Kostek, Ozlem Ercelep, 1 Ibrahim Vedat Bayoglu1 Evaluation of Clinicopathological Characteristics and Survival Outcomes of Young Gastric Cancer Patients, Single Center Experience DOI: 10.14744/ejmi.2023.43719 EJMI 2023;7(3):296–302

R. ARIKAN, Üstün H. S., Demircan N. C., Işik S., Telli T. A., Yaşar A., Çelebi A., Majidova N., Sever N., ÇELİKEL Ç., Sari M., Ercelep Ö., Köstek O., Bayoğlu I. V. Et Al., "Prognostic Significance of Mucinous Histology in Metastatic Colorectal Cancer Patients Treated with Regorafenib, " Journal of Oncological Science, vol.9, no.2, pp.53-61, 2023

MAJIDOVA, N., EREN, Ö. C., YAŞAR, A., KIRCALI, M. F., GÜREN, A. K., KOCAASLAN, E.,... & KÖSTEK, O. (2025). Colorectal Cancer Metastasizing to the Thyroid Gland: A Rare and Interesting Case.

Güren, A. K., Kocaaslan, E., & Çelebi, A. Denovo Metastatic Primary Gastric Ewing Sarcoma/Primitive Neuroectodermal Tumor–13 Years Follow-up-: Case Report and Review of Literature. JM Med Stu 2025, 2(1), 105-108.

Ghivi, S., Olgun, S., Çınar, C., Yıldız, C., Kocakaya, D., Ermerak, N. O.,... & Yıldızeli, B. (2025). Clinical and radiological findings in relation to histopathological results of pulmonary nodule resections. Marmara Medical Journal, 38(2), 121-128.

Güren, A. K., Çakır, İ., Majidova, N., Sever, N., Kocaaslan, E., Erel, P.,... & Köstek, O. (2025). Oncological perspective on Kaposi sarcoma: A single-centre experience. Marmara Medical Journal, 38(1), 9-14.

Özlem Ercelep, Neoadjuvan Kemoradyoterapi Alan Lokal İleri Rektum Kanserli Hastalarda Patolojik Tam Yanıtı Predikte Eden Faktörler 3. Uluslararası Hipokrat tıp ve sağlık bilimleri kongresi 6-7 Mart 2020, Ankara

Nazim Can Demircan, Ozkan Alan, Tuğba Basoglu Tuylu, Tuğba Akin Telli, Rukiye Arikan, Furkan Cuma Cicek, Özlem Ercelep, Mehmet Akif Ozturk, Ilknur Alsan Cetin, Rabia Ergele, Ilker Tinay, Nalan Akgul Babacan, Serap Kaya, Faysal Dane, Perran Fulden Yumuk Impact of the Charlson Comorbidity Index on Dose-Limiting Toxicity and Survival in Locally Advanced and Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib or Pazopanib 9. Avrasya Üroonkoloji Kongresi 16-20 Kasım 2019

Abdussamet Çelebi, Alper Yaşar, Nadiye Sever, Nargiz Majidova, Rukiye Arıkan, Selver Işık, Murat Sarı, Özlem Ercelep, İbrahim Vedat Bayoğlu, Osman Köstek The relationship between c-erbB2 positivity and disease-free survival in operated non-metastatic gastric cancer. The relationship between c-erbB2 positivity and disease-free survival in operated non-metastatic gastric cancer International Association of surgeons Gastroenterologists and Oncologists IASGO 2022

Hilal Sağıroğlu Üstün, Abdussamet Çelebi, Ibrahim Vedat Bayoğlu, Rukiye Arıkan, Alper Yaşar, Nargiz Majidova, Nadiye Sever, Murat Sarı, Selver Işık, Özlem Ercelep, Osman Köstek What is the ideal sequence for regorafenib in the treatment of metastatic colorectal cancer? 12th International Gastrointestinal Cancers Conference 2022

Javid Hüseynov, Alper Yaşa, Abdussamet Çelebi, Nargiz Majidova, Nadiye Sever, Rukiye Arıkan, Selver Işık, Tuğba Akın Telli, Murat Sarı, Özlem Ercelep, İbrahim Vedat Bayoğlu, Osman Köstek Evaluation of Factors Influencing on Progression-Free Survival and Overall Survival of Patients Requesting First-line Tyrosine Kinase Inhibitor for Metastatic Renal Cell Carcinoma 12. Avrasya Üroonkoloji kongresi 2022

Özlem Ercelep, Perran Fulden Yumuk Evaluation of Recent Targeted Treatments Güncel Göğüs Hastalıkları Serisi 2018; 6 (3): 74-84 ISSN 2147-5776

Özlem Ercelep, Faysal Dane Glioblastomda İlk Seri Sistemik Tedavi Türkiye Klinikleri Dergisi Tıbbi Onkoloji Erişkin Santral Sinir Sistemi Tümörleri özel sayısı 2019. p.58-60.

Özlem Ercelep The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future Bull Urooncol 2020; 19: 104-106 DOI: 10.4274/uob.galenos.2020.1447

Selver Işık, Özlem Ercelep Türkiye Klinikleri Dergisi Tıbbi Onkoloji Hedefe Yönelik Ajanların İlaç Etkileşimleri ve Yan Etkileri Küçük Molekül Tirozin Kinaz İnhibitörleri EGFR Hedefli Tedaviler (erlotinib, afatinib, gefitinib, osimertinib, dakomitinib, lapatinib) 2021.p.5-8

Zeynep Alaca Topçu, Mehmet Akif Öztürk, Mahmut Emre Yıldırım, Rukiye Arıkan, Tuğba Başoğlu, Nazım Can Demircan, Tuğba Akın Telli, Özlem Ercelep, Faysal Dane, Perran Fulden Yumuk İLERLEMİŞ MESANE KANSERİNDE PROGNOSTİK FAKTÖRLER 14. Üroonkoloji kongresi 6-10 kasım 2019

Nadiye Sever, Alper Yaşar, Rukiye Arıkan, Özlem Ercelep, Murat Sarı Metastatik Her 2 Pozitif Meme Kanserinde Hastaların Demografik Özellikleri ve Tedavi Yanıt Sonuçları, Tek Merkez Deneyimi 6. Karadeniz Meme Kongresi 9-11 mart 2023

Nadiye Sever, Abdussamet Çelebi, Gamze Nur Aktaş, Murat Sarı, Özlem Ercelep, İbrahim Vedat Bayoğlu1 KOMORBIDITESI OLAN METASTATIK AKCIĞER KANSERI HASTALARINDA ANTIHIPERTANSIF TEDAVI KULLANIMININ SAĞ KALIM ÜZERINE ETKISI, TEK MERKEZ DENEYIMI 10. Türk Tıbbi Onkoloji Kongresi 26-30 Nisan 2023

Nadiye SEVER, Alper YAŞAR, Rukiye ARIKAN, Özlem ERCELEP, Murat SARI, İbrahim Vedat BAYOĞLU NÖROENDOKRİN TÜMÖR TANILI OLUP KAPESİTABİN+TEMOZOLAMİD ALAN HASTALARMIZIN DEMOGRAFİK ÖZELLİKLERİ VE TEDAVİ YANIT DEĞERLENDİRMESİ, TEK MERKEZ DENEYİMİ 10. Nadir tümörler sempozyumu 24-26 Şubat 2023

Alper Yaşar, Rukiye Arıkan, Nadiye Sever, Özlem Ercelep, İbrahim Vedat Bayoğlu S-11 YAYGIN EVRE KÜÇÜK HÜCRELİ AKCİĞER KANSERLİ HASTALARDA PLATİN DİRENCİ İÇİN PREDİKTİF FAKTÖRLER İZMİR UĞUR YILMAZ ONKOLOJİ GÜNLERİ “ IX. NADİR TÜMÖRLER SEMPOZYUMU “ 25-27 Şubat 2022

Nargiz Majidova, Alper Yaşar, Abdussamet Çelebi, Nadiye Sever, Selver Işık, Özlem Ercelep, Murat Sarı, Osman Köstek, İbrahim Vedat Bayoğlu ERKEN EVRE İNVAZİV LOBÜLER MEME KANSERİ HASTALARIN DEMOGRAFİK ÖZELLİKLERİ VE TAKİP SONUÇLARI, TEK MERKEZ DENEYİMİ 3. Meme Kanseri Sempozyumu, 26-28 Mayıs 2022

Özkan Alan, Özlem Ercelep, Tuğba Akın Telli, Tuğba Başoğlu Tüylü, Tunç Öneş, Emine Bozkurtlar, Nalan Akgül Babacan, Tunç Laçin, Bedrettin Yıldızeli, Hasan Fevzi Batırel, Serap Kaya, Faysal Dane1, Perran Fulden Yumuk1PRİMER TÜMÖRÜN PREOPERATİF SUV(MAX) DEĞERİ OPERE KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİNDE PROGNOSTİK FAKTÖR OLABİLİR Mİ ? VIII. Ulusal akciğer kanseri kongresi 4-7 Ekim 2018

Özlem Ercelep, Özkan Alan, Tuğba Telli, Tuğba Tüylü, Nalan Babacan, Serap Kaya, Faysal Dane1, Tunc Lacin, Emine Bozkurtlar, Tunc Öneş, Fulden Yumuk AKCİĞER ADENOKARSİNOMU HİSTOLOJİK ALT TİPLERİNE GÖRE PET CT SUV DEĞERLERİ VE SAĞKALIM SONUÇLARININ KARŞILAŞTIRILMASI VIII. Ulusal akciğer kanseri kongresi 4-7 Ekim 2018

Özlem Ercelep Kemik koruyucu tedaviler, Onkolojide Palyatif Bakım ve Yaşam Sonu Desteği ISBN 978-605-258-954-0 bölüm 19/sayfa 127-131